Renasant Bank’s Gilead Sciences GILD Stock Holding History

Renasant Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,040	Closed	-$228K	–	175
2023 Q3	$228K	Sell	3,040 -7,567	-71%	-$582K	0.19%	151
2023 Q2	$817K	Sell	10,607 -3,351	-24%	-$267K	0.67%	46
2023 Q1	$1.16M	Sell	13,958 -1,029	-7%	-$85.2K	0.9%	28
2022 Q4	$1.29M	Sell	14,987 -4,098	-21%	-$325K	0.97%	23
2022 Q3	$1.18M	Sell	19,085 -633	-3%	-$39.9K	1.04%	22
2022 Q2	$1.22M	Buy	19,718 +1,092	+6%	+$67.6K	0.99%	23
2022 Q1	$1.11M	Buy	18,626 +4,146	+29%	+$265K	0.75%	36
2021 Q4	$1.05M	Buy	14,480 +6,552	+83%	+$451K	0.72%	37
2021 Q3	$553K	Buy	7,928 +2,725	+52%	+$191K	0.44%	71
2021 Q2	$358K	Sell	5,203 -21	-0.4%	-$1.4K	0.27%	111
2021 Q1	$338K	Sell	5,224 -861	-14%	-$55.5K	0.27%	114
2020 Q4	$355K	Buy	+6,085	New	+$367K	0.29%	115

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renasant Bank's GILD Position: Q4 2023 in Review

Renasant Bank sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,040 shares — an estimated $228K sold.

Renasant Bank first reported a position in GILD in Q4 2020 and held it in 12 quarters. The position peaked at $1.29M in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Renasant Bank reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Renasant Bank sold 3,040 Gilead Sciences shares in Q4 2023, an estimated $228K.
Renasant Bank first reported a position in Gilead Sciences in Q4 2020 and held it in 12 quarters.
Renasant Bank's Gilead Sciences position peaked at $1.29M in Q4 2022.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Renasant Bank's 13F filing for Q4 2023, filed 12 Feb 2024.